SoftOx Solutions AS (OSL:SOFTX) ROE % Adjusted to Book Value: -2.87% (As of Dec. 2025)


What is SoftOx Solutions AS ROE % Adjusted to Book Value?

SoftOx Solutions AS OSL:SOFTX -2.91% ROE % Adjusted to Book Value is -2.87% as of Dec. 2025.

SoftOx Solutions AS's ROE % for the quarter that ended in Dec. 2025 was -25.17%. SoftOx Solutions AS's PB Ratio for the quarter that ended in Dec. 2025 was 8.78. SoftOx Solutions AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -2.87%.

SoftOx Solutions AS ROE % Adjusted to Book Value Related Terms

SoftOx Solutions AS ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for SoftOx Solutions AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SoftOx Solutions AS ROE % Adjusted to Book Value Chart

SoftOx Solutions AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.32 -15.41 -13.11 -303.62 -2.09

SoftOx Solutions AS Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.48 11.07 -4.51 -12.19 -2.87

OSL:SOFTX vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, SoftOx Solutions AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SoftOx Solutions AS ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SoftOx Solutions AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SoftOx Solutions AS's ROE % Adjusted to Book Value falls into.


SoftOx Solutions AS ROE % Adjusted to Book Value Calculation

SoftOx Solutions AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-18.31% / 8.78
=-2.09%

SoftOx Solutions AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-25.17% / 8.78
=-2.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -2.87% mean?
SoftOx Solutions AS (OSL:SOFTX) has a ROE % Adjusted to Book Value of -2.87% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on SoftOx Solutions AS and its competitors.
Is SoftOx Solutions AS's ROE % Adjusted to Book Value too high?
SoftOx Solutions AS's current ROE % Adjusted to Book Value is -2.87%.
How does SoftOx Solutions AS's ROE % Adjusted to Book Value compare to VRTX and REGN?
SoftOx Solutions AS's ROE % Adjusted to Book Value of -2.87% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on SoftOx Solutions AS and its competitors. SoftOx Solutions AS's current ROE % Adjusted to Book Value is -2.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftOx Solutions AS stock overvalued right now?
SoftOx Solutions AS (OSL:SOFTX) has a current ROE % Adjusted to Book Value of -2.87%. The current ROE % Adjusted to Book Value is -2.87%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For SoftOx Solutions AS (OSL:SOFTX), the current ROE % Adjusted to Book Value is -2.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SoftOx Solutions AS Business Description

Other Exchanges 6FV:Germany
Address Fridtjof Nansens vei 16, Lysaker, NOR, 1366
SoftOx Solutions AS is a clinical-stage pharmaceutical company. It offers antimicrobial solutions for Wound and Skin Care. It has developed an effective antimicrobial solution to combat biofilm, viral, and antimicrobial-resistant infections. The technology is based on extensive research and development in partnership with Nordic research institutes.